Skip to main content
Informational

Data use:

We use cookies and similar tools to make your use of this website easy and to keep it working properly. We may share data about you and how you use the site with third parties, such as analytics and marketing partners. Learn more in our Privacy Policy and Terms of Use. By continuing to use the site, you agree to this.

E-book

Trends shaping pharma strategy in 2026

How should pharma manufacturers strategically evolve as the industry shifts? Get expert insights from Advisory Board and Optum® Life Sciences.

How to prioritize what matters

Each year, Advisory Board and Optum® Life Sciences experts analyze the trends shaping the future for life sciences organizations. This year’s e-book spotlights 5 critical shifts that require strategic consideration in 2026. These shifts call for a more adaptive, data-informed and stakeholder-aware approach to strategy. 

Related healthcare insights

View all

Case study

Identifying patients' bone fracture risk

Optum Life Sciences experts used real-world data to assist in the testing of an algorithm designed to assess for osteoporosis risk.

Article

Catalyze the use of RWE in life sciences

Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.

Article

Integrated RWD: The key to accelerating innovation

To maximize the value of clinical innovations, you need dimensional, robust data. Learn about leveraging integrated cost and clinical data.